Q3 2017 Holdings
Filed 2017-11-14 | 63 holdings | $28.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Versartis Inc | COM | 92529L102 | $674 | 275,000 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $688 | 100,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $924 | 187,450 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $983 | 120,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $1.2K | 64,410 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.3K | 53,500 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $1.7K | 30,000 | 0.0% |
| Iridex Corp(IRIX) | COM | 462684101 | $1.9K | 199,519 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $2.0K | 100,000 | 0.0% |
| PTC Therapeutics Inc(PTCT)Call | COM | 69366J200 | $2.0K | 100,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $2.0K | 35,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.8K | 1,100,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $2.8K | 850,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.0K | 200,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $3.4K | 235,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $3.6K | 75,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $3.7K | 400,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT)Call | COM | 00900T107 | $3.7K | 150,000 | 0.0% |
| Currencyshs Brit Pound Ster | BRIT POUND STE | 23129S106 | $3.9K | 30,100 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $4.0K | 700,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.1K | 35,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $4.1K | 109,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.2K | 65,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $4.5K | 100,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.5K | 100,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $4.8K | 75,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $5.0K | 200,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $5.1K | 50,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $5.6K | 345,284 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $5.7K | 400,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD)Call | COM | 45845P108 | $5.8K | 100,000 | 0.0% |
| Patterson Companies Inc(PDCOEUR) | COM | 703395103 | $6.2K | 160,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $6.8K | 550,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $7.0K | 135,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $7.1K | 80,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.6K | 50,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $7.8K | 250,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.8K | 65,000 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $8.8K | 75,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $9.1K | 950,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Put | COM | 78667J108 | $9.3K | 150,000 | 0.0% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $9.4K | 300,000 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $9.5K | 50,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $9.6K | 150,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $10.1K | 104,539 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.1K | 324,400 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $10.4K | 561,510 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $10.5K | 115,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $13.1K | 350,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.8K | 225,000 | 0.0% |